Advertisement
Screener

PFIZER INC (PFE) Business Combination, Contingent Consideration, Liability

2.8 / 5 stars · 68/120 Roast Me

PFIZER INC Business Combination, Contingent Consideration, Liability

PFIZER INC (PFE) had Business Combination, Contingent Consideration, Liability of $1.80 billion as of 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Balance Sheet › Liabilities

us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2026-02-26

  • 2025-12-31: Business Combination, Contingent Consideration, Liability $1.80B.
  • 2024-12-31: Business Combination, Contingent Consideration, Liability $517.00M.
  • 2023-12-31: Business Combination, Contingent Consideration, Liability $692.00M.
  • 2022-12-31: Business Combination, Contingent Consideration, Liability $645.00M.
Period endBusiness Combination, Contingent Consideration, Liability
2025-12-31$1.80B
10-K · filed 2026-02-26
2024-12-31$517.00M
10-K · filed 2026-02-26
2023-12-31$692.00M
10-K · filed 2025-02-27
2022-12-31$645.00M
10-K · filed 2024-02-22
2021-12-31$697.00M
10-K · filed 2023-02-23
2020-12-31$689.00M
10-K · filed 2022-02-24
2020-09-27$701.00M
10-Q · filed 2020-11-05
2020-06-28$727.00M
10-Q · filed 2020-08-06
2020-03-29$669.00M
10-Q · filed 2020-05-07
2019-12-31$711.00M
10-K · filed 2021-02-25
2018-12-31$988.00M
10-K · filed 2020-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64